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ABSTRACT
The catalogue of Somatic Mutations in Cancer
(COSMIC) (http://www.sanger.ac.uk/cosmic/) is the
largest public resource for information on somati-
cally acquired mutations in human cancer and
is available freely without restrictions. Currently
(v43, August 2009), COSMIC contains details of
1.5-million experiments performed through 13423
genes in almost 370000 tumours, describing over
90000 individual mutations. Data are gathered
from two sources, publications in the scientific liter-
ature, (v43 contains 7797 curated articles) and the
full output of the genome-wide screens from the
Cancer Genome Project (CGP) at the Sanger
Institute, UK. Most of the world’s literature on
point mutations in human cancer has now been
curated into COSMIC and while this is continually
updated, a greater emphasis on curating fusion
gene mutations is driving the expansion of this infor-
mation; over 2700 fusion gene mutations are now
described. Whole-genome sequencing screens are
now identifying large numbers of genomic
rearrangements in cancer and COSMIC is now dis-
playing details of these analyses also. Examination
of COSMIC’s data is primarily web-driven, focused
on providing mutation range and frequency statis-
tics based upon a choice of gene and/or cancer
phenotype. Graphical views provide easily
interpretable summaries of large quantities of
data, and export functions can provide precise
details of user-selected data.
INTRODUCTION
The Catalogue of Somatic Mutations in Cancer
(COSMIC) database is designed to annotate, hold,
navigate and display the published literature on somatic
mutations in human cancer. Huge amounts of information
have been generated on this subject, but these are diﬃcult
to examine collectively due to their format or distribution.
COSMIC collects all this detailed information together
in one place by precisely and exhaustively curating the sci-
entiﬁc literature, both for known cancer genes and large
systematic screens, and combines it with the large analyses
from the Cancer Genome Project (CGP) at the Wellcome
Trust Sanger Institute, UK. The website over this database
is designed to provide an easy interface to query this
complex data, providing graphical and tabulated aggregate
views allowing detailed examinations and summary
analysis of mutation range and prevalence, both from a
gene and cancer type perspective. Most recently, whole-
genome sequencing results have been included, overviewed
in a new circular diagram with separate displays for navi-
gation and viewing of this new data.
DATABASE CONTENT
The data in COSMIC is derived from two sources.
The literature curation eﬀort uses original publications
as the data source to maximize the precision of the data
obtained, no indirect curation of external databases
has been performed. Genes are highlighted for curation
by their presence in the Cancer Gene Census [(1);
http://www.sanger.ac.uk/genetics/CGP/Census/], focusing
on these well-characterized genes and collecting large
quantities of information (for example, over 13000
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curated in KRAS). Genes promoting cancer via point
mutations have been primarily targeted since they have a
great impact in carcinogenesis and a large quantity of
information to conﬁdently generate mutation range
and prevalence statistics. Cancer-promoting gene fusion
mutations are also being curated, as there are many
more genes promoting tumour growth via fusion events
than point mutations (1). The literature curation process is
largely manual, gradually accumulating the quantity of
data currently available over 9 years. As information is
entered to COSMIC by dedicated trained curators,
software systems check each datapoint for accuracy and
integrity. Large systematic candidate gene screens are
additionally being curated in a semi-automated fashion,
with initial interpretation of large result sets automated,
followed by further manual and software checks. This
should allow the inclusion of all somatic mutations with
potential impact in human cancer. These will serve as a
resource for whole cancer genome resequencing data. All
literature curation genes in COSMIC are updated each
release (six releases are scheduled per year) with data
curated from recent papers to present the most recent
somatic mutation reports.
Additionally, COSMIC serves as the portal to access
in-house somatic mutation screening data from the system-
atic resequencing studies undertaken by the CGP. Such
information is now available for over 4000 genes
screened. More recently, CGP data includes low coverage
whole genome resequencing screens (2), utilizing next-
generation sequencing technologies which can precisely
identify genome-level rearrangements previously invisible
in both karyotypic and candidate gene screen procedures.
Each mutation found has been resequenced several times
and examined by scientiﬁc staﬀ for conﬁdent conﬁrmation.
All annotations in COSMIC require the tumour sample
to have a phenotypic classiﬁcation. This comprises a
description of where the tumour was found (e.g. lung)
and its morphology (e.g. non-small cell lung cancer,
NSCLC). Usually broken down into increasingly special-
ized deﬁnitions (e.g. skin, face, NS: malignant melanoma,
lentigo maligna, NS), these allow the mutation data to
be navigated at diﬀerent levels. For instance it is useful to
examine KRAS mutations from a broad primary site per-
spective; lung tumours show a very diﬀerent mutation
spectrum in this gene than large intestine cancers.
However, examining Lentigo Maligna (a subclassiﬁcation
of melanoma) in isolation, shows mutations in only four
genes, only two of which have signiﬁcant frequencies
(BRAF, NRAS). COSMIC’s phenotype deﬁnition system
has been built for this purpose, allowing layered and very
precise classiﬁcation of each tumour. Rather than adhere
to an existing standard of tumour classiﬁcation, COSMIC
has developed it from the ground up to be as useful as
possible for this purpose. During curation the published
classiﬁcation for each tumour is recorded before being
translated into COSMIC’s system. This system (not
independently published) is described in further detail on
COSMIC’s ‘additional info.’ page (http://www.sanger.ac.
uk/genetics/CGP/cosmic/add_info/), including a listing of
classiﬁcation translations.
Each mutation recorded in COSMIC is given a unique
identiﬁer, a series of details and a single statement that
precisely deﬁnes it (e.g. ‘c.1799T>A’; ‘p.V600E’;
‘chr2:g.140099605T>A’). This mutation ‘syntax’ is
derived from the HGVS nomenclature recommendations
(3). Coding domain annotations receive a ‘c.’ syntax,
indicating the mutation is located on a cDNA CDS
co-ordinate and a ‘p.’ syntax indicating an amino acid
co-ordinate. Gene fusions receive an ‘r.’ syntax indicating
the co-ordinate is relative to the gene pair’s mRNA
co-ordinates, an important distinction as the UTR
sequences can be signiﬁcant in these novel products.
Finally, mutations can also receive a ‘g.’ syntax indicating
nucleotides on the golden path which are involved in the
mutation. Details of these syntaxes are discussed at length
at http://www.genomic.unimelb.edu.au/mdi/mutnomen/.
DATA ACCESS
The website is focused on presenting complex phenotype-
speciﬁc mutation data in an easily interpretable format,
usually best presented graphically. Initial entry into the
system is usually via selection of a gene or cancer tissue
type (phenotype), either using ‘browse by’ features where
one is presented with a list to choose from, or the ‘search’
box where any text can be typed for a COSMIC database
search. Whilst browsing by gene is fairly straightforward,
browsing by phenotype can become complex, with
multiple increasingly specialised phenotype choices;
for instance one can navigate to ‘lung’ only, or to the
very speciﬁc ‘lung, right lower lobe; carcinoma,
adenocarcinoma’. Acceptable search terms include not
only gene names or phenotype terms, but also COSMIC
database IDs, or mutation description syntaxes (e.g.
‘p.V600E’). Once a choice is made, summary information
is presented with mutation counts and frequencies; the
gene summary page provides a mutation spectrum map
and many links to external resources; the phenotype
(tissue) summary page provides lists of mutated genes.
These pages lead into the histogram page, where most
examination of the data occurs. Mutations are graphically
displayed for the selected gene, as a histogram of single-
base substitutions, together with a map of insertions,
deletions and complex replacement mutations (Figure 1).
The histogram immediately shows the type of cancer gene
selected, easily identiﬁable by its mutation signature.
Figure 1a shows BRAF, a gain-of-function oncogene,
requiring very speciﬁc sequence changes for oncogenic
activation [the missense mutation p.V600E represents
75% of all muations found in this gene (n mutated=
13885)]. Conversely, Figure 1b shows CDKN2A; cancer
can only progress after this key tumour suppressor gene
is inactivated. As the histogram shows, this can happen
in a number of ways across the entire gene’s length
(n mutated=3262). Tabulated breakdowns of the data
are available under the graphic either by phenotype or
sequence change, and additional messages will appear if
further fusion mutation data is available for the gene. The
histogram can display mutations either by CDS or amino
acid co-ordinates and, most usefully, can be zoomed to
Nucleic Acids Research, 2010,Vol.38, Database issue D653Figure 1. The Histogram page forms the core of the COSMIC website, showing the mutation range for each gene selected. The frequencies of each
single base substitution are shown in the histogram itself and each deletion, insertion and complex substitution are indicated below as triangles
(deletions point down in blue, insertions point up in red) or bars (which indicate the length of sequence being replaced). Below the mutations, long
single-colour bars indicate structural domains, providing links to external databases including Pfam and InterPro. Two histograms are shown to
demonstrate the range of mutation distributions observed; (a) BRAF shows the classical gain-of-function spectrum, whereby very speciﬁc mutations
are required to activate growth promotion, in this case most frequently a c.1799T>A substitution; (b) CDKN2A (p16) is a tumour suppressor gene,
only allowing growth promotion when its activity is absent (‘loss-of-function’). Tumourigenic mutations only need to inactivate the gene, shown here
as a range of mutations across the gene’s length, particularly including a large quantity of frame shifting insertions and deletions.
D654 Nucleic AcidsResearch, 2010, Vol.38,Database issuescrutinize particular regions of a gene more closely, with
the tables below reﬂecting the details in the zoomed region
of the graphic. Additionally, once a gene is being viewed, a
phenotype can be speciﬁed (at any level of detail) and both
the graphic and table will be redrawn to reﬂect the new
parameters. In this way, the histogram page can be used in
a process of circular navigation, constantly specializing
from general to speciﬁc queries, gaining much knowledge
in the process. Links from this core page direct users
to summaries and further details of mutations and
publications, together with an export function, to output
the information onscreen in a spreadsheet format.
Gene fusion mutations are indicated within the
summary and histogram pages, but in separate sections;
if a gene is fused with another, or a sample contains such
a mutation, a separate indicator is shown to direct the
user to a summary page which overviews the mutation
frequencies and phenotypes associated with fusions
between the two selected genes, again with graphic and
tabulated displays. Fusions are deﬁned by exon content,
including UTR exons which are signiﬁcant in some fusion
events, leading to displays largely focused on deﬁning the
breakpoint with respect to the nearest exon of each gene.
The ‘r.’ mutation syntax records not the breakpoint
position, but the mRNA content from each gene
(including intronic or non-templated sequences were
appropriate).
Samples which have undergone whole-genome
sequencing receive summary annotation in the form of a
‘circos’ diagram [Figure 2; (4)]. This is due to the quantity
and complexity of the data collected by these studies,
which includes extensive lists of coding and non-coding
point mutations, copy number variations and genomic
rearrangements. While most of this information can be
displayed in linear tracks against standard karyotype
ideograms, the non-linear nature of interchromosomal
rearrangements is much more suited to a circular
diagram, and COSMIC has now standardized on this
format for whole-genome sequencing experiments. All
known genotypic information for a sample is included in
the diagram, regardless of its originating methodology.
Forming a starting point for the investigation of these
highly annotated samples, the ring of coding mutations
provides links into the standard cosmic gene-centric
views, the CNV track links into the CGP’s SNP array-
based CGH site (http://www.sanger.ac.uk/cgi-bin/
genetics/CGP/CGH_home.cgi) for further evaluation
of copy number abnormalities, and the structural
rearrangements link into a subsystem of pages to
examine these in more detail.
The main COSMIC website (blue pages) overviews
the whole database, showing all curated information.
However, within the larger COSMIC websystem,
multiple subdomains exist to navigate subprojects
independently, each colour-coded for easy recognition.
A yellow page (http://www.sanger.ac.uk/genetics/CGP/
Classic/) summarizes the information curated from the
scientiﬁc literature providing summaries and links into
COSMIC. Two entire websites, colour-coded copies of
the main cosmic system, overview the CGP’s contribution
to COSMIC. The CGP resequencing studies, focused
candidate gene screens sequencing large numbers of
tumour samples through over 4000 genes are presented
on a red COSMIC site (http://www.sanger.ac.
uk/genetics/CGP/Studies/). In green, the cancer cell line
project displays results of a systematic characterization
of the mutant genotypes of almost 800 well-known
cancer cell lines (http://www.sanger.ac.
uk/genetics/CGP/CellLines/). Particularly in the green
website, mutations are only included if they are known,
or are highly likely to, have a signiﬁcant impact on the
oncogenesis of the tumour examined; an additional
datasheet is available describing mutations of unknown
signiﬁcance resulting from the cell line project.
While the COSMIC websites are geared toward easy
graphical navigation, custom data mining and large-scale
analysis often requires the data in a diﬀerent format. For
this purpose, the content of each release is summarized in
a series of very large spreadsheets and placed on a
dedicated FTP site (ftp://ftp.sanger.ac.uk/pub/CGP/
cosmic) for downloading. For those needing to mine the
full content of COSMIC, each release is also available
as a relational database export in Oracle 10 format, but
supporting this requires signiﬁcant IT infrastructure.
COSMIC data is also available outside of the COSMIC
system. Where possible, all co-ordinate data in COSMIC
has been located on the human genome (i.e. genes, exons,
mutations). This has allowed the integration of COSMIC
data into the Ensembl genome browser (http://www
.ensembl.org) via DAS [distributed annotation system,
(5)]. Once COSMIC DAS tracks are turned on (either
via Ensembl conﬁguration or a link on the gene or
mutation summary pages), COSMIC annotations for
both genes and mutations can be examined in a genomic
context (Figure 3). For the 62 main curated genes,
mutation annotations in a peptide structure context
(uniprot annotations) are also available as a DAS track.
COSMIC DAS tracks are all available through
http://www.dasregistry.org/. A much lengthier discussion
of the data in COSMIC and its navigation is available as
a Protocol document (6).
FUTURE WORK
As the complexity and scope of the data in COSMIC
expands, more tools are needed to mine the data and ref-
erence it to external systems, and new systems are
currently being built with this in mind. Especially
notable amongst these upgrades is a new Biomart which
will soon be available for COSMIC. Especially designed
for the mining of complex datasets, Biomart (7) allows the
speciﬁcation of any number of predicate sets, querying the
COSMIC database and returning the appropriate data in
tabulated form, with links back in to the COSMIC
websystem where appropriate. This has been designed to
encompass the full scope of the published COSMIC data
rather than any subdomain. One of the strengths of
Biomart is its ability to federalize several independent
systems and query them together returning a coherent
dataset combined from all. Using the external database
identiﬁers in COSMIC already, the COSMIC biomart
Nucleic Acids Research, 2010,Vol.38, Database issue D655has been federated to Ensembl to allow the retrieval of
gene and genome annotations surrounding regions of
interest in cancer. Further federalization is possible and
we are examining other ways of integrating COSMIC with
external resources. It is expected this addition to COSMIC
should be available before the end of 2009.
DISCUSSION
COSMIC comprises a number of subtly diﬀerent data
domains. Ninety percent of the mutation content
adheres to the original goal of curating the world’s litera-
ture on known cancer genes. However, with the speed
of DNA sequencing accelerate rapidly, tumour analysis
is becoming less focused on single genes and it is not
unusual to ﬁnd studies which instead analyse thousands.
COSMIC has held CGP data from these screens for years
due to its use as a prepublication data release site
for primary tumour and cell line analyses. However,
curating published systematic screens has traditionally
been more diﬃcult due to the large number of mutations
and genes, and the lack of automatable informatic access.
In order to include these large-scale studies in COSMIC,
the curation systems have now been extended and the
inclusion of such data has begun with the release of the
Sjoblom et al. screen of breast and colorectal tumours in
Figure 2. COSMIC has now standardized on Circos diagrams (4) to display genome-wide mutation analyses for a sample. Concentric rings display
diﬀerent data for the same sample, all located to the same genomic co-ordinates. On the outside of the circle, the chromosomes of the standard
reference genome are coloured, numbered and appropriately scaled. Moving from the chromosome indicators to the centre of the circle, blue lines
indicate the presence of coding point mutations in the coding domains of genes, a ring of histograms indicate the copy number of each genomic
segment, red bars indicate the presence of small intra chromosomal rearrangements and green lines link chromosomes where large intra chromosomal
rearrangements have been observed.
D656 Nucleic AcidsResearch, 2010, Vol.38,Database issuethe full CCDS gene set (8). While the curation of point
mutations in COSMIC is an ongoing activity, the number
of uncurated genes remaining is rapidly reducing and has
allowed a redirection of eﬀort to include oncogenic gene
fusion events, with many more genes involved than
point mutations (1). The genetic analysis of human
cancer has also begun to lose its coding-domain focus,
with full-genome resequencing of tumours now
underway, generating tens of thousands of mutations per
sample, together with many genomic rearrangements.
These are now being released into COSMIC, using the
Circos diagram (4) as a basis for summarizing genome-
wide data, particularly useful for presenting complex
intra- and inter-chromsosmal relationships. COSMIC
will continue to curate the world’s literature on somatic
mutations in cancer, but it will increasingly develop with
the aim of displaying and navigating data from whole
cancer genome resequencing eﬀorts.
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